# Pyoderma gangrenosum

> Pyoderma gangrenosum is a rare inflammatory skin condition that causes painful, fast-growing ulcers, most often on the lower legs. It isn't an infection and has nothing to do with gangrene. Treatment is medical, aiming to calm the immune system.

Guide in [Wounds and ulcers](https://footanklelowerlimb.com.au/learn/topics/wounds-and-ulcers), from Foot Ankle Lower Limb: https://footanklelowerlimb.com.au/learn/pyoderma-gangrenosum
Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPod (Podiatrist) on 22 November 2026.
Next review by 22 November 2027.

- **It's a rare inflammatory skin condition** that causes painful ulcers, most often on the lower legs, and it isn't an infection.
- **It often goes with another condition,** such as inflammatory bowel disease or arthritis.
- **It can look like an infection,** and no single test confirms it, so other causes have to be ruled out.
- **Minor skin injury or surgery can trigger it** or make it worse.
- **Treatment calms the immune system,** and these medicines need close medical monitoring.

## What is pyoderma gangrenosum, and how common is it?

Pyoderma gangrenosum (often shortened to PG) is a long-lasting inflammatory skin condition that causes painful ulcers with irregular, purplish edges [1]. It usually appears on the lower legs [1]. It often starts as a tender red lump or pustule (a pus-filled spot) that quickly breaks down into a large ulcer with undermined edges [2].

Despite the name, PG is not related to gangrene [3]. It isn't an infection either: it comes from inflammation of the skin that isn't caused by germs [4]. Doctors class it as a neutrophilic dermatosis, a skin condition with a dense build-up of inflammatory cells called neutrophils [5].

PG is rare. Worldwide it is estimated to affect around 3–10 people per million each year [6].

## What causes it, and who gets it?

The cause isn't known, but an overactive, poorly regulated immune system seems to be involved [6]. Several theories point to overactive white blood cells and immune signals, but these are still theories rather than established causes [1].

PG is often linked to other conditions. In 50–70% of cases it goes with inflammatory bowel disease, blood cancers or joint conditions such as rheumatoid arthritis [6]. The pattern differs with age: inflammatory bowel disease is more common in people under 65, while rheumatoid arthritis and cancers of solid organs are more common in people aged 65 or older [7].

Injury can set it off. Pathergy means the skin breaking down after a trivial injury, and 20–30% of people report that their PG began this way [6]. Surgery, biopsies or other skin injury can trigger new or worse ulcers [4][6][7]. PG has been described after breast surgery, including breast reduction.

## What does it look like, how is it diagnosed, and what can make it serious?

PG usually appears suddenly as a small pimple, red bump or blood blister [3]. The skin then gives way to a sore that hurts and can grow fast, and more than one sore can form nearby [3]. The edge is typically raised, undermined and blue-purple, with redness around it, and the pain is often intense [4][6]. Fever and feeling generally unwell can also occur [4].

There is no specific test for PG. Diagnosis rests mainly on clinical judgement and on ruling out other causes [5][6]. A biopsy (a small skin sample) from the edge of the ulcer supports the diagnosis but can't confirm it alone [8]. Experts have proposed criteria built around such a biopsy, but these haven't yet been tested in routine practice [9].

### Features that can make it serious

A painful, rapidly worsening ulcer with an undermined purple edge that doesn't respond to antibiotics, and whose tissue cultures grow no germs, can point to PG rather than infection [4]. Carrying on with infection-focused treatment alone can delay the right care [4]. PG is serious and can progress quickly [3][10].

After breast surgery, PG can be mistaken for a wound infection or tissue death [11][12]. Clues include pain greater than expected, separate wounds around the nipples that leave them untouched, and a poor response to antibiotics [11][12]. A raised CRP (a blood marker of inflammation) doesn't separate PG from infection [11][13]. Infection can still develop in PG, and sepsis (a severe whole-body reaction to infection) is a serious risk [13].

### What else it could be

Because no test confirms PG, other causes of ulcers have to be considered: infection, venous or arterial ulcers (from poor blood flow), vasculitis (inflamed blood vessels), cancer, injury and drug reactions [5][8]. A painful ulcer that is growing or not healing can resemble several of these, so it isn't something to self-diagnose.

> [!tip] Try this
> If you have an ulcer that is changing, jot down when it started, how fast it has grown, how painful it is, and any recent injury, bite or surgery at the site. It gives your clinician a clear history.

## What helps first?

PG is treated medically from the start, and the treatment depends on how severe it is. Mild to moderate ulcers are treated on the skin, mainly with steroid creams or similar [6]. Severe PG needs medicines that work throughout the body: steroid tablets, other immune-dampening medicines (immunosuppressants), or both [5][6].

The support for these treatments is limited. Steroid tablets and a few immunosuppressants have the most backing, but it comes from small, varied, lower-quality studies [14]. There is no single agreed treatment, because few studies have compared the options [1].

Choosing a medicine involves weighing risks. Steroid tablets caused more serious side effects, mostly serious infections, than a commonly used alternative immunosuppressant [2]. These medicines need close monitoring, with regular follow-up visits with the treating doctor [5].

## What helps if that isn't enough?

When first treatments aren't enough, other immunosuppressants are added, including TNF-alpha inhibitors (targeted medicines that block one inflammation signal), under medical supervision [5]. Some of these targeted medicines are among the better-supported options, though the evidence is still small and varied [14]. There is no agreed pathway for what comes next [1]. Any added immunosuppressant carries benefits and side effects, which can be talked through with the treating doctor before and during treatment.

Wounds are handled gently. Removing tissue from the wound is kept to a minimum, and a skin graft is considered only once drug treatment is under way [12]. This is because surgery and other skin injury can trigger or worsen PG [4][5][12][13].

## How long does it take, and can it come back?

No healing timeframe is clear yet. Early recognition and prompt immunosuppressive treatment are considered essential for a better outlook [10], and early treatment can reduce the risk of scarring [3].

Surgery can trigger PG to return, and people who have had PG seem more prone to it coming back when they are operated on again [4]. Because people who have had PG appear more prone to it returning after an operation, a surgical or procedure team may need to know about that history so they can plan around the risk. Regular follow-up with the treating doctor lets the condition be watched closely [5].

## Common questions

### Is pyoderma gangrenosum contagious?

No. It isn't caused by germs; it comes from sterile inflammation of the skin. People once believed an infection was behind it, but it later became clear that this isn't the case. The treatments used aim to calm the immune system rather than to kill germs.

### Can children get pyoderma gangrenosum?

Yes, though it rarely affects children. The most commonly reported pattern is several scattered ulcers. Inflammatory bowel disease is the underlying condition reported most often in children, but more than half of children have no underlying disease.

### What are the side effects of the medicines used for pyoderma gangrenosum?

Medicines that act on the whole body can cause serious problems, including severe infections, a hole in the bowel (perforation), a burst abdominal aortic aneurysm and sudden kidney injury. That is why people taking them are closely supervised, with regular follow-up visits.

## Further reading

- [Pyoderma gangrenosum on Clindice](https://clindice.com/pyoderma-gangrenosum)
- [Pyoderma gangrenosum](https://fr.patient.info/doctor/dermatology/pyoderma-gangrenosum-pro), Patient.info
- [Pyoderma gangrenosum](https://www.stmarkshospital.nhs.uk/wp-content/uploads/2017/09/smh-patient-leaflets-pyoderma-ganrenosum.pdf), NHS
- [Pyoderma Gangrenosum: Causes, Symptoms & Treatments](https://my.clevelandclinic.org/health/diseases/17825-pyoderma-gangrenosum-pg), Cleveland Clinic
- [Written by: Leela Terry and Dr Hannah Wainman Page 1 of 3 Approved by: Drug & Therapeutics Committee September 2023 Review date: September 2026](https://www.gloshospitals.nhs.uk/media/documents/Infliximab_for_Pyoderma_Gangrenosum.pdf), NHS
- [Leg Ulcers](https://rms.cornwall.nhs.uk/rms/primary_care_clinical_referral_criteria/rms/primary_care_clinical_referral_criteria/dermatology/leg_ulcers), NHS

## Sources

1. Treatments for Pyoderma Gangrenosum: A Systematic Review and Single-Arm Meta-Analysis of Systemic Therapies · Kaur M, Diaz MJ, Anthony M et al. · International Wound Journal · 2025. https://doi.org/10.1111/iwj.70733
2. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial · Ormerod AD, Thomas KS, Craig FE et al. · BMJ (Clinical Research Ed.) · 2015. https://doi.org/10.1136/bmj.h2958
3. Pyoderma gangrenosum · nidirect · 2018. https://www.nidirect.gov.uk/conditions/pyoderma-gangrenosum
4. Infection mimicking skin condition: pyoderma gangrenosum · Burlage E, Mulder JWCM, Nellensteijn JM et al. · BMJ Case Reports · 2022. https://doi.org/10.1136/bcr-2021-247770
5. ACD A-Z of Skin - Pyoderma gangrenosum · ACD · 2015. https://www.dermcoll.edu.au/atoz/pyoderma-gangrenosum/
6. Pyoderma gangrenosum: a systematic review · Cozzani E, Gasparini G, Parodi A · Giornale Italiano di Dermatologia e Venereologia · 2014. https://pubmed.ncbi.nlm.nih.gov/25213386/
7. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum · Ashchyan HJ, Butler DC, Nelson CA et al. · JAMA Dermatology · 2018. https://doi.org/10.1001/jamadermatol.2017.5978
8. Dual-Targeted Therapy in Refractory Pyoderma Gangrenosum: A Focused Systematic Review of Convergent Pathway Targeting · Shanshal M, Karanasios G · Dermatology and Therapy · 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13650218/
9. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts · Maverakis E, Ma C, Shinkai K et al. · JAMA Dermatology · 2018. https://doi.org/10.1001/jamadermatol.2017.5980
10. The great imitator with no diagnostic test: pyoderma gangrenosum · Alonso-León T, Hernández-Ramírez HH, Fonte-Avalos V et al. · International Wound Journal · 2020. https://doi.org/10.1111/iwj.13466
11. Postsurgical Pyoderma Gangrenosum in Breast Surgery: An Updated Systematic Review, Takeaways, and the 6 Commandments · Caddia G, Voulliaume D, Dettori L et al. · Aesthetic Surgery Journal · 2025. https://doi.org/10.1093/asj/sjaf095
12. Pyoderma Gangrenosum After Breast Surgery: Diagnostic Pearls and Treatment Recommendations Based on a Systematic Literature Review · Tuffaha SH, Sarhane KA, Mundinger GS et al. · Annals of Plastic Surgery · 2016. https://doi.org/10.1097/sap.0000000000000248
13. Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management · Ye MJ, Ye JM · Dermatology Research and Practice · 2014. https://doi.org/10.1155/2014/461467
14. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials · Partridge ACR, Bai JW, Rosen CF et al. · The British Journal of Dermatology · 2018. https://doi.org/10.1111/bjd.16485

---

This is general information, not advice about your own situation. To discuss your issues, book with one of our podiatrists. In an emergency, call 000.
